Back to Search Start Over

Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging: a COSMIC study.

Authors :
Röhr S
Pabst A
Riedel-Heller SG
Jessen F
Turana Y
Handajani YS
Brayne C
Matthews FE
Stephan BCM
Lipton RB
Katz MJ
Wang C
Guerchet M
Preux PM
Mbelesso P
Ritchie K
Ancelin ML
Carrière I
Guaita A
Davin A
Vaccaro R
Kim KW
Han JW
Suh SW
Shahar S
Din NC
Vanoh D
van Boxtel M
Köhler S
Ganguli M
Jacobsen EP
Snitz BE
Anstey KJ
Cherbuin N
Kumagai S
Chen S
Narazaki K
Ng TP
Gao Q
Gwee X
Brodaty H
Kochan NA
Trollor J
Lobo A
López-Antón R
Santabárbara J
Crawford JD
Lipnicki DM
Sachdev PS
Source :
Alzheimer's research & therapy [Alzheimers Res Ther] 2020 Dec 18; Vol. 12 (1), pp. 167. Date of Electronic Publication: 2020 Dec 18.
Publication Year :
2020

Abstract

Background: Subjective cognitive decline (SCD) is recognized as a risk stage for Alzheimer's disease (AD) and other dementias, but its prevalence is not well known. We aimed to use uniform criteria to better estimate SCD prevalence across international cohorts.<br />Methods: We combined individual participant data for 16 cohorts from 15 countries (members of the COSMIC consortium) and used qualitative and quantitative (Item Response Theory/IRT) harmonization techniques to estimate SCD prevalence.<br />Results: The sample comprised 39,387 cognitively unimpaired individuals above age 60. The prevalence of SCD across studies was around one quarter with both qualitative harmonization/QH (23.8%, 95%CI = 23.3-24.4%) and IRT (25.6%, 95%CI = 25.1-26.1%); however, prevalence estimates varied largely between studies (QH 6.1%, 95%CI = 5.1-7.0%, to 52.7%, 95%CI = 47.4-58.0%; IRT: 7.8%, 95%CI = 6.8-8.9%, to 52.7%, 95%CI = 47.4-58.0%). Across studies, SCD prevalence was higher in men than women, in lower levels of education, in Asian and Black African people compared to White people, in lower- and middle-income countries compared to high-income countries, and in studies conducted in later decades.<br />Conclusions: SCD is frequent in old age. Having a quarter of older individuals with SCD warrants further investigation of its significance, as a risk stage for AD and other dementias, and of ways to help individuals with SCD who seek medical advice. Moreover, a standardized instrument to measure SCD is needed to overcome the measurement variability currently dominant in the field.

Details

Language :
English
ISSN :
1758-9193
Volume :
12
Issue :
1
Database :
MEDLINE
Journal :
Alzheimer's research & therapy
Publication Type :
Academic Journal
Accession number :
33339532
Full Text :
https://doi.org/10.1186/s13195-020-00734-y